Prevalence of sarcopenia-causing medicines (V1)

• Research type

  Research Study

• Full title

  Exploratory Study on the Prevalence of Sarcopenia-Promoting Medicines in Patients with Sarcopenia and Falls

• IRAS ID

  354863

• Contact name

  Kamaldeep Sahota

• Contact email

  kamaldeep.sahota1@nhs.net

• Sponsor organisation

  Medway Maritime Hospital

• Clinicaltrials.gov Identifier

  354863, IRAS project ID; 1353, Medway Maritime Hospital R&I

• Duration of Study in the UK

  0 years, 5 months, 31 days

• Research summary

  Sarcopenia, characterised by the loss of muscle mass and function, is a common condition among the elderly and is often associated with increased risk of falls. Certain medications, such as glucocorticoids, statins, and some antipsychotics, may exacerbate sarcopenia, leading to a higher incidence of falls. This study aims to explore the prevalence of such medicines in patients diagnosed with sarcopenia who have experienced falls. Understanding the impact of these medications on sarcopenia and fall risk can inform clinical guidelines and improve patient outcomes
  

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  25/PR/0876

• Date of REC Opinion

  31 Jul 2025

• REC opinion

  Further Information Favourable Opinion